Avigilon Video Analytics Patents - What Should A Manufacturer Do?

I have probably read all posts on Avigilon & VA Patents here however it is not clear whether Avigilon has already approached any company with their patent portfolio. Have they? If yes then does somebody have any details?

What strategy do you have for this possible risk? Taking into account that their (OV) patents cover such basic things as a tripwire it looks pretty bad for the...

****. ** ******, *** **** **** ***** *** *** ****** and ********* ** ***** **** *** **** *** ** ***** & ****** ******* ** ******* ***** *********?

********** * *** *** **** **** *** ********** **** **** without ********* ********* ******** ****** ****** ** ***** *********. **** needs ** *** ****** ***** ** **** ********** **** **** with ********. ** **** * **** **** *** ** **** have **** ******* ** ** ***** *** ***** ****. *** product *** **** ****** ** ** ******** ** *** ******* one ****-**-**** ***** *** ******. *** ** **** *********** ***** for *** ****** ***********. ********* ** **** *** **** **** to ****** ** ****** ******* ** *** ***** (********* *** will ** *** *** ********* ** *** **** *** **********) and ** *** **** **** *** ** ** ************ ******* it ***** ***** ** ******** *********** ** **** **** **** it ****** ***** (** *** ***** *** *** ** ****** much *******) ** **** ** *** ** **** ***** **** prospect ********.

Login to read this IPVM discussion.
Why do I need to log in?
IPVM conducts unique testing and research funded by member's payments enabling us to offer the most independent, accurate and in-depth information.

***.
*** *** ***** **** * **** ********* **** ****.
* *** **** ***** **** *** *** ******** ******* ** breach ** ******* *******.
* ***'* ******** *** **** ** *** ** *** *** means ** ***** ***** ****** ** *** ******.
*** *** ** ***** ***** ********* *** **** **** *** permanent ***** ********** **** ***** **** * **** *** **** ache.

***** ******* *** * **** *********** ****** * ***** ******* contacting * ****** *******.
* ***'* ***** ****** ** **** *** **** *** *** help **** **** ****** ** ******* (** *** ******* *********) are ****** *** ********* ** **** **** **** ****.

******

** ******, * **** *** **** ** ******* (***** **** I ** *** ****** ****** ** ****** **** ***).
* ** *** ****** ** **** *** ***** ******** **** but * **** ** **** ** **** ******** ** ***** manufacturers ** **** *****.

"******** *** ******* ********** *** ******* **** ***** ****** *********. Have ****? ** *** **** **** ******** **** *** *******?"

******** *** ******* ******** **** **** *** ******** *** ** some *********. ***** *********** *** **** **** **** ***** ** start **** * ******* ****** ** ********* *** **** ******. I ***'* **** *** ******* ***** **** **** *** ****** for **** '*******' *** **** **** **** **** **** ** look **** ******* ****** *** ** ******* *** **** ******* original ********* **** *** *** ** ******* *** ***** *******.

"** ******, *** **** **** ***** *** *** ****** *** resources ** ***** **** *** **** *** ** ***** & medium ******* ** ******* ***** *********?"

**********, *** *** **** **** *** **** *** ****** ****** when ** **** * *** ***** ***. *** *******, ***** settled, ***** *******, **** *******, ***.

"********* ** **** *** **** **** ** ****** ** ****** patents ** *** *****"

*** ******* ***** ** ****** ** *** ** *** ******, generally, *** *** *** **** *** ****** ** ********'* ******** unless *** ******* **** ** *** ** ********* ***** ********* of **** ******* / ************ **** ******.

"** ** ************ ******* ** ***** ***** ** ******** *********** in **** **** **** ** ****** *****"

** *** **** ** *** ********. ** * ******* ******* (presumably * **********), ** **** ********* **** ****, *** ****** be **** ** ** ****. ** *****, ******** **** *** a *** ** **** ******* *** **** **** *** **** or ***** ***. **** ** **** **** ** ** ***** for ***** ********* **** **** ** ******* ********* *** **** on *** **** *******.

"*** *** ***** **** * **** ********* **** ****."

********. ***** ***** **** ******* ** **** ******** ******* *** pay **** * *** ******* *** ******* (********) ***, ** your ********** ******* *****, ** **** *** ****** **** * difference.

** * *** ** **** *****, *'* ******** **** ******** Avigilon, *** ** * ********** **** *** ** ******, *** then *** **** ** **** ** **** *********, ********, *********, etc.

****: ** ****** ** ***** ********* ***** ** ********** *********, as ****** ******** **** *** ******* **** *** ** **** more ** * **** *****.

***** *** *** **** ******** ****.

********** ******** ****** ********** *** * ** ******** **. *******, it ** * ***-*** **** *** * **** ****** ***** it. ****, *** ***** ******** (***** **) **** ** ***** satisfied ** ** **** ** ********* **** *** ****-***** *******' holder. ** *** **** ****, ********* **** ******* ** * some *** **** ******** **** ********* *******. * ***** ******** some ** ** ******** ***** **: ******* ** ****** ** make * **** **** ******** ** ***. **** ******* **** negative *** *** ****** ***********. ****, ** **** ** ** option ** ** ***** *** **** ** * *** ******* (this **** "*************" *** "******** ********" *** ******* *****), *** deal **** ******** ** **** * ******** *****.

***** ** ** *** ******* ******* ** ** ***** ** a ******* ****** ** ***********.

"** *** **** ****, ********* **** ******* ** * **** way **** ******** **** ********* *******. * ***** ******** **** of ** ******** ***** **: ******* ** ****** ** **** a **** **** ******** ** ***. **** ******* **** ******** for *** ****** ***********."

****??? ** ** *** **** * ****** ******* ********* **** Avigilon, **** **** *** **** **** ***? ******? * ***** that. ****, *****, *****, ****, ********* *** * **** ** other ********* ******* **** ** **********, ***** *** *** ***** by ********.

****** ** ***** ********* ****** *** ****** ********* ******* ********, tell **** ** ** *** ***** ******** * ***** *** invalidate *** *******. *********, ********** * ***** ******* ** ******* and ******.

* *** *** **** *** **** *** ********* :) *** companies ** **** **** ** *** **** *** ********. **** are **** ********** *** ** ** ******* ***** **** ********.

* ** *** **** *** ******* ******* *** *** **** assume **** ***** ** ** ***** **** ******** **** ** consistent *** **** ** **** *** *** **** ********** ** a ********.

* ********** **** **** ************* ** *** ***** ********. *********, based ** ***** ***** ****** ** *********** **** ***** *****, it ** **************.

* **** ** *** *** *** **** ***** **** ** against *** ** *** *** * *******. *** ** **** is ***** ******, ** ** ***** ******.

* ***** ******** **** ** ** ******** ***** **: ******* we ****** ** **** * **** **** ******** ** ***. Most ******* **** ******** *** *** ****** ***********...

*** ***** ****** *** **** ** **** **** ** * formality, **** ****** ********. *** ***** ******?